Biology subjects

Ngeow, J.

Publications and source records attributed to Ngeow, J..

2 recordsLinked to original sources

bioRxiv2025

High-throughput plasma proteomic platforms: Insights from a multi-ethnic Asian cohort

We compared three leading affinity-based and mass-spectrometry-based proteomic platforms (SomaScan11K, Olink Explore HT, Orbitrap Astral with Seer Proteograph [MS-Seer]) in a multi-ethnic Asian cohort, to inform biomarker discovery and functional genomic studies of global populations. We found limited overlap (1,740 proteins) across the three platforms, with modest correlations (0.34-0.10). SomaScan had lower missingness (<1%) and CV (<10%), compared to Olink (51%, 23%) and MS-Seer (12%, 19%). The new assays in Olink Explore HT (absent in Explore3072) primarily drove its higher missingness and CV. The number of phenotypic associations varied by trait, while the number of genetic associations (cis-pQTLs at P<5e-08) were similar for Olink and SomaScan. Protein levels differed between ethnicities, with SomaScan identifying more ethnicity-differentiated proteins than Olink (FDR<0.05). Finally, SomaScan ANML normalization attenuated biologically relevant associations in our study. These findings underscore the importance of platform evaluation and data normalization strategies for application in large-scale, diverse population cohorts.

bioinformatics↗

bioRxiv2024

Pervasive ancestry bias in variant effect predictors

Variant effect predictors (VEPs) - computational tools that assess the potential impact of genetic variants - have become increasingly vital for clinical variant interpretation. Currently, most VEPs used in variant prioritisation have been trained on datasets of clinically curated or population-derived variants. These datasets, however, disproportionately represent individuals of European descent. We hypothesised that this bias may lead to unequal VEP performance across different populations. To test this, we evaluated the scoring patterns of 52 VEPs for missense variants across 14 ancestry groups. We observe striking disparities: some VEPs predict a markedly higher proportion of damaging variants in underrepresented populations, such as those of Malay descent, compared to individuals of European ancestry. In contrast, VEPs that do not rely on clinical or population data predict more consistent pathogenicity burdens across ancestry groups. Moreover, we could closely link these discrepancies across methods to biases in training data. Our findings underscore the urgent need to adopt tools that minimise ancestry bias to ensure fairer and more accurate variant effect prediction and genetic diagnoses for all populations.

bioinformatics↗